International Isotopes receives FDA nod for I-131

By AuntMinnie.com staff writers

February 11, 2020 -- Radioisotope manufacturer International Isotopes received clearance from the U.S. Food and Drug Administration (FDA) for use of its sodium iodide-131 (I-131) radiopharmaceutical to treat hyperthyroidism and thyroid carcinomas.

International Isotopes plans to launch I-131 for commercial distribution soon and hopes to use its approval as a springboard to advance development for other products.


Copyright © 2020 AuntMinnie.com
 
Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking
account: